With Android phones dominating the India market, Apple is planning to consolidate its logistics operations, set up a dedicated distribution center for iPhones, iPads and computers in India reports the Economic Times.
Citing two senior industry officials, the report says that Apple is turning to its global logistic partner and one of Europe’s largest logistics companies, D.B. Schenker, to set up operations at Bhiwandi near Mumbai.
This distribution center in India will ensure the availability of Apple products at retail stores and set a common pricing for offline and online sales. This will ultimately enable the company to exercise greater control over the supply chain of its products, reports The Tech Portal.
Five months ago, during an earnings call, Tim Cook said: “India is now one of our fastest growing markets. In the first three quarters of this fiscal year, our iPhone sales in India were up 51% year on year. We’re looking forward to opening retail stores in India down the road, and we see huge potential for that vibrant country.”
December 23, 2016 No Comments
Camarillo, California-based Semtech Corporation has teamed up with Tata Communications to launch India’s first applications center to facilitate LoRa, or long range networks, technology in Mumbai.
The Economic Times reports a joint statement by the two companies which said that this center will allow enterprise customers and Internet of Things solution providers to deploy and test their applications over a LoRaWAN-based low power, wide area network. As many as 35 IoT applications can be deployed across Bangalore, Delhi and Mumbai. Research firm IDC estimates that the global IoT market will grow to $7.1 trillion by 2020, up from $1.9 trillion in 2013.
“The current LoRaWAN-based network allows millions of devices to be connected, and our goal is to have 200 million end devices connected by 2019,” V.S. Shridhar, Senior Vice President and Head – Internet of Things, Tata Communications said.
December 22, 2016 No Comments
The Trump Organization has more active projects underway in India — at least five — than anywhere else outside North America, reports NPR. And even if Donald Trump goes through with his declaration that he will exit his businesses to avoid any conflict of interest arising from his global enterprises, the entity in charge of his business will likely reap benefits from the Trump name.
In India, Trump’s partners in real estate (where the Trump name — in gold — graces projects) pay the Trump Organization for use of the Trump name, which to many, is synonymous with quality. So though he has not invested in these properties, the Indian brand-licensing agreements have the potential to earn the Trump Organization at least several million dollars says Ramesh Jogani a Mumbai-based real estate developer. Priced at $2 million for each unit, construction is underway at the 75-story, gold-facade Mumbai Trump Tower, with half of the 412 units already sold.
However, Mumbai property consultant Gulam Zia predicts, “Any permission, any license, any favor that this product attracts because of the brand will be noted, magnified, spoken about, debated and fought over in the media.”
December 18, 2016 No Comments
Philadelphia’s Drexel University alumnus Mihir Shah, and Matthew Campisi have created the iBreastExam scanner which is a hand-held device that enables health workers to perform breast health examinations in virtually any setting, not just hospitals. “Mammography isn’t feasible in India due to high equipment cost and the lack of radiologists,” says Shah.
iBreastExam uses patented ceramic sensors developed at Drexel University to detect subtle variations in breast tissue, and offers the following features:
- Bilateral breast exam within 5 minutes (with results at the point-of-care)
- Accuracy to detect clinically relevant breast lesions is higher than 85%
- Usable by any health-worker or doctor. No pain, No radiation
Forbes reports that the company UE Lifesciences Inc., with offices in both Mumbai and Philadelphia, will sell the product on a pay-per-use model instead of direct sales, which will enable doctors to immediately start offering private, safe and pain-free breast exams. Shah says he has kept the costs flexible; doctors at high-end private hospitals are charged in the range of $10-$15 per test, whereas village clinics will be charged only $1.
December 15, 2016 No Comments
Chicago, Illinois-based Abbott will set up an innovation and development center in Mumbai, India aimed at developing new drug formulations, new indications, dosing, packaging and other differentiated offerings to feed into its global branded generics business that clocked sales of $3.7 billion last year. The center will act as a “hub” and ship products to at least 30 countries that will further develop the products to suit local needs, reports the Economic Times.
Without divulging the amount the company will invest, Michael Warmuth, Executive VP, Established Pharmaceuticals division of Abbott said the proposed investments will double the company’s local scientific manpower. He described India as a “cornerstone of success” making specific reference as a “talent exporter” and how it helped Abbott gain a scientific edge in its other countries of operations.
Commenting on the overall regulatory and economic environment in India, Warmuth said the regulators are trying to do the right things but he maintained it would be good to see the environment a little more stable when making investment decisions. “Overall that does not really change our view on the market itself,” he added.
November 10, 2016 No Comments